U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740187) titled 'A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Female Fertility' on July 28.
Brief Summary: This study evaluates the effects of a daily dietary supplement (WeNatal For Her) on markers of female fertility, reproductive health, and sexual health over three menstrual cycles. Forty female participants who are currently trying to conceive will take three capsules of the supplement each morning with their first meal.
The study is a single-arm, unblinded hybrid trial. Participants will complete questionnaires at Baseline and on Days 2-5 of Cycles 1, 2, and 3, and will attend a local Labcorp location for blood draws ...